The Efficacy of Platinum Chemotherapy in a Japanese Malignant Melanoma Patient With a BRCA2 Mutation Identified by Gene Panel Testing

A BRCA2 mutation increases the chance of developing cancer and has been linked to several diseases, including hereditary breast, ovarian, pancreatic, and prostate cancers. We present a case of advanced malignant melanoma treated with platinum-containing chemotherapy and demonstrate a momentarily fav...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayanagi-Hara, Reiko, Saito-Sasaki, Natsuko, Okada, Etsuko, Sawada, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586885/
https://www.ncbi.nlm.nih.gov/pubmed/37868454
http://dx.doi.org/10.7759/cureus.45572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586885/
https://www.ncbi.nlm.nih.gov/pubmed/37868454
http://dx.doi.org/10.7759/cureus.45572

Ejemplares similares